Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 26 | 26 | 0 |
| Shares | 2.84M | 2.90M | +63.3K (+2.2%) |
| Value | $13.2M | $8.17M | −$5.06M (−38.2%) |
New holders (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 14,207 | $40.0K | 0.00% |
| M Holdings Securities, Inc. | 10,750 | $30.0K | 0.00% |
| Citigroup Inc | 3,453 | $10.0K | 0.00% |
| UBS Group AG | 3,280 | $9.00K | 0.00% |
Sold out (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Marshall Wace, LLP | 79,836 | $373.0K |
| Two Sigma Securities, LLC | 22,354 | $104.0K |
| Schonfeld Strategic Advisors LLC | 20,200 | $94.0K |
| Parametric Portfolio Associates LLC | 10,466 | $49.0K |